 Connection
Cynthia Firnhaber to Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
This is a "connection" page, showing publications Cynthia Firnhaber has written about Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.189 |
|
|
|
-
Cespedes MS, Kang M, Kojic EM, Umbleja T, Godfrey C, Webster-Cyriaque JY, Masih R, Firnhaber C, Grinsztejn B, Saah A, Cu-Uvin S, Aberg JA. Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1. Papillomavirus Res. 2018 12; 6:15-21.
Score: 0.160
-
Kojic EM, Kang M, Cespedes MS, Umbleja T, Godfrey C, Allen RT, Firnhaber C, Grinsztejn B, Palefsky JM, Webster-Cyriaque JY, Saah A, Aberg JA, Cu-Uvin S. Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women. Clin Infect Dis. 2014 Jul 01; 59(1):127-35.
Score: 0.030
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|